Intellin

Macclesfield, United Kingdom Founded: 2004 • Age: 22 yrs
Offers an AI-based mobile app for effective diabetes management and monitoring.

About Intellin

Intellin is a company based in Macclesfield (United Kingdom) founded in 2004. It operates as a B2C. Intellin operates in a competitive market with competitors including Healthline, BeatO, Glooko, Health2Sync and Dr. Diary Co, among others.

Operational Areas

Competitors of Intellin

Intellin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Healthline, BeatO, Glooko, Health2Sync and Dr. Diary Co, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
healthline.com1999San Francisco, United States$154.01M300
Provider of online health information pltaform
beatoapp.com2015Delhi, India$50.83M93
Smartphone-enabled glucometers and diabetes management apps are provided.
glooko.com2010Palo Alto, United States$201M121
Diabetes management is enabled via glucose meters and mobile apps.
health2sync.com2013Taipei, Taiwan$30.5M–
Provider of an app for tracking blood glucose level
drdiary.co.kr2017Seoul, South Korea$12.22M–
Provider of app for diabetes management
socialdiabetes.com2011Barcelona, Spain––
Mobile health solution that connects doctors and diabetic patients
tidepool.org2012San Francisco, United States$1.5M3
SaaS for Type 1 diabetes management is provided by Tidepool.
xploro.health2019Manchester, United Kingdom$1.7M11
AI-led platform offering health and disease prevention information
Premium access

Detailed competitors of Intellin

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Intellin

10 companies that operate in the same segment as Intellin (Diabetes), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of devices for continuous glucose monitoring and manual insulin delivery
2008San Diego, California, United StatesUSD 100.73 MUSD 1.02 B2,650
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Small molecule drugs for various therapeutic areas are developed.
1995United StatesUSD 165 MUSD 49.8 M103
Implantable continuous glucose monitoring systems are provided for diabetes management.
1996Germantown, United StatesUSD 175.46 MUSD 22.47 M117
Developer of a closed-loop automated insulin delivery system
2014Milpitas, California, United StatesUSD 214.51 M–133
Provider of workforce healthcare solutions
2015New York, New York, United StatesUSD 107.87 M–166
Diabetes care and reversal programs are provided to patients.
2021Bengaluru, Karnataka, IndiaUSD 26.7 MUSD 5.07 M677
Provider of smart devices for diabetes management for patients and doctors
2014San Francisco, California, United StatesUSD 245.2 M––
Genetically engineered cell therapies are developed for multiple disorders.
2018Seattle, Washington, United StatesUSD 821 M–194
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Intellin

Intellin was founded in 2004.

Intellin is headquartered in Macclesfield, United Kingdom. It is registered at Macclesfield, Cheshire, United Kingdom.

Intellin operates with a B2C model, focusing on healthcare technology, providing digital health services, developing user-friendly mobile apps, and diabetes management. Offers an AI-based mobile app for effective diabetes management and monitoring. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Intellin's top competitors include BeatO, Healthline and Glooko.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available